Table 1.
CpG | Chr:Position (hg19) | Nearest gene | Reduced model | Full model | ||||||
---|---|---|---|---|---|---|---|---|---|---|
n | Z | P | Q | FDR | n | Z | P | |||
cg24202936 | 11:50257256 | SEPTIN7P11 | 5359 | 5.38 | 7.58 × 10–8 | 0.03 | 0.04 | 4930 | 5.28 | 1.30 × 10–7 |
cg17417856 | 19:50191637 | PRMT1;ADM5 | 4917 | –4.95 | 7.42 × 10–7 | 0.15 | 0.28 | 4526 | –4.40 | 1.11 × 10–5 |
cg01506471 | 7:3990479 | SDK1 | 5359 | –4.81 | 1.52 × 10–6 | 0.21 | 0.3 | 4930 | –4.00 | 6.41 × 10–5 |
cg14547240 | 4:15428750 | C1QTNF7 | 5359 | –4.71 | 2.48 × 10–6 | 0.25 | 0.3 | 4930 | –4.17 | 3.10 × 10–5 |
cg21547371 | 3:52869521 | MUSTN1 | 5359 | –4.65 | 3.30 × 10–6 | 0.25 | 0.3 | 4930 | –4.06 | 4.95 × 10–5 |
cg03116124 | 1:231293208 | TRIM67 | 5129 | –4.64 | 3.54 × 10–6 | 0.25 | 0.31 | 4700 | –4.58 | 4.63 × 10–6 |
cg06809326 | 17:20799526 | CCDC144NL-AS1 | 5359 | 4.57 | 4.80 × 10–6 | 0.28 | 0.34 | 4930 | 3.44 | 5.88 × 10–4 |
cg13476133 | 7:44185646 | GCK | 5359 | 4.55 | 5.46 × 10–6 | 0.28 | 0.36 | 4930 | 4.03 | 5.65 × 10–5 |
cg14133539 | 9:104568 | FOXD4 | 4917 | –4.53 | 5.98 × 10–6 | 0.28 | 0.38 | 4526 | –4.45 | 8.41 × 10–6 |
cg17577122 | 22:19511967 | CLDN5 | 5359 | 4.50 | 6.88 × 10–6 | 0.29 | 0.4 | 4930 | 4.79 | 1.68 × 10–6 |
cg23586595 | 4:84034390 | PLAC8 | 5359 | 4.45 | 8.45 × 10–6 | 0.32 | 0.43 | 4930 | 3.93 | 8.36 × 10–5 |
cg23054394 | 3:140784675 | SPSB4 | 5359 | –4.42 | 9.88 × 10–6 | 0.34 | 0.45 | 4930 | –4.01 | 6.07 × 10–5 |
The reduced model is adjusted for age, sex, study site (if applicable), total (intra)cranial volume (cm3), white blood cell proportion (%), technical covariates and genetic principal components. The full model is additionally adjusted for BMI, smoking status and systolic and diastolic blood pressure measures. Chr = chromosome; EA = European ancestry; FDR = local false discovery rate value; n = number of subjects tested for the CpG; P = P-value; Q = Q-value; SE = standard error; Z = Z-score.